LONDON and NEW YORK, May 23, 2011 -
OXFORD, England, May 23, 2011 -
COLOGNE, Germany, May 23, 2011 -
SYDNEY, May 23, 2011 - Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced successful results of a major phase 2 clinical study that demonstrated efficacy of VivaGel(R) for the treatment of bacterial vaginosis (BV).
AMSTERDAM, May 23, 2011 - - RNAi Data for Hypercholesterolemia Presented at ASGCT Annual Meeting